Efficacy and Safety of Esketamine for Supplemental Analgesia During Elective Cesarean Delivery: A Randomized Clinical Trial
- PMID: 37083664
- PMCID: PMC10122167
- DOI: 10.1001/jamanetworkopen.2023.9321
Efficacy and Safety of Esketamine for Supplemental Analgesia During Elective Cesarean Delivery: A Randomized Clinical Trial
Abstract
Importance: Epidural anesthesia is a primary choice for cesarean delivery, but supplemental analgesics are often required to relieve pain during uterine traction.
Objective: To investigate the sedative and analgesic effects of intravenous esketamine administered before childbirth via cesarean delivery with the patient under epidural anesthesia.
Design, setting, and participants: This multicenter, double-blind randomized clinical trial assessed 903 women 18 years or older who had full-term single pregnancy and were scheduled for elective cesarean delivery with epidural anesthesia in 5 medical centers in China from September 18, 2021, to September 20, 2022.
Intervention: Patients were randomized to receive intravenous injection of 0.25 mg/kg of esketamine or placebo before incision.
Main outcomes and measures: The coprimary outcomes included scores on the numeric rating scale of pain (an 11-point scale, with 0 indicating no pain and 10 indicating the worst pain; a difference of ≥1.65 points was clinically meaningful) and Ramsay Sedation Scale (a 6-point scale, with 1 indicating restlessness and 6 indicating deep sleep without response; a difference of ≥2 points was clinically meaningful) immediately after fetal delivery. Secondary outcomes included neonatal Apgar score assessed at 1 and 5 minutes after birth.
Results: A total of 600 women (mean [SD] age, 30.7 [4.3] years) were enrolled and randomized; all were included in the intention-to-treat analysis. Immediately after fetal delivery, the score on the numeric rating scale of pain was lower with esketamine (median [IQR], 0 [0-1]) than with placebo (median [IQR], 0 [0-2]; median difference, 0; 95% CI, 0-0; P = .001), but the difference was not clinically important. The Ramsay Sedation Scale scores were higher (sedation deeper) with esketamine (median [IQR], 4 [3-4]) than with placebo (median [IQR], 2 [2-2]; median difference, 2; 95% CI, 2-2; P < .001). The neonatal Apgar scores did not differ between the 2 groups at 1 minute (median difference, 0; 95% CI, 0-0; P = .98) and at 5 minutes (median difference, 0; 95% CI, 0-0; P = .27). Transient neurologic or mental symptoms were more common in patients given esketamine (97.7% [293 of 300]) than in those given placebo (4.7% [14 of 300]; P < .001).
Conclusions and relevance: For women undergoing cesarean delivery under epidural anesthesia, a subanesthetic dose of esketamine administered before incision produced transient analgesia and sedation but did not induce significant neonatal depression. Mental symptoms and nystagmus were common but transient. Indications and the optimal dose of esketamine in this patient population need further clarification, but study should be limited to those who require supplemental analgesia.
Trial registration: ClinicalTrials.gov Identifier: NCT04548973.
Conflict of interest statement
Figures
![Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10122167/bin/jamanetwopen-e239321-g001.gif)
![Figure 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10122167/bin/jamanetwopen-e239321-g002.gif)
Comment in
-
Routine Prophylactic Esketamine for the Prevention of Maternal Pain During Cesarean Delivery.JAMA Netw Open. 2023 Apr 3;6(4):e239331. doi: 10.1001/jamanetworkopen.2023.9331. JAMA Netw Open. 2023. PMID: 37083670 No abstract available.
Similar articles
-
Perioperative Adjunctive Esketamine for Postpartum Depression Among Women Undergoing Elective Cesarean Delivery: A Randomized Clinical Trial.JAMA Netw Open. 2024 Mar 4;7(3):e240953. doi: 10.1001/jamanetworkopen.2024.0953. JAMA Netw Open. 2024. PMID: 38446480 Free PMC article. Clinical Trial.
-
Esketamine Combined with Dexmedetomidine to reduce Visceral Pain During elective Cesarean Section Under Combined Spinal-Epidural Anesthesia: A double-Blind Randomized Controlled Study.Drug Des Devel Ther. 2024 Jun 18;18:2381-2392. doi: 10.2147/DDDT.S460924. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38911034 Free PMC article. Clinical Trial.
-
Association between esketamine interventions and postpartum depression and analgesia following cesarean delivery: a systematic review and meta-analysis.Am J Obstet Gynecol MFM. 2024 Mar;6(3):101241. doi: 10.1016/j.ajogmf.2023.101241. Epub 2024 Jan 21. Am J Obstet Gynecol MFM. 2024. PMID: 38262519 Review.
-
The effect of low-dose esketamine on pain and post-partum depression after cesarean section: A prospective, randomized, double-blind clinical trial.Front Psychiatry. 2023 Jan 4;13:1038379. doi: 10.3389/fpsyt.2022.1038379. eCollection 2022. Front Psychiatry. 2023. PMID: 36683972 Free PMC article.
-
Patient-controlled analgesia with remifentanil versus alternative parenteral methods for pain management in labour.Cochrane Database Syst Rev. 2017 Apr 13;4(4):CD011989. doi: 10.1002/14651858.CD011989.pub2. Cochrane Database Syst Rev. 2017. PMID: 28407220 Free PMC article. Review.
Cited by
-
Comparison of Effects of Propofol Combined with Different Doses of Esketamine for ECT in the Treatment of Depression: A Randomized Controlled Trial Protocol.Neuropsychiatr Dis Treat. 2024 May 17;20:1107-1115. doi: 10.2147/NDT.S463028. eCollection 2024. Neuropsychiatr Dis Treat. 2024. PMID: 38774255 Free PMC article.
-
The Relationship Between Perioperative Use of Esketamine and Postpartum Depression Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Neuropsychiatr Dis Treat. 2024 May 16;20:1041-1048. doi: 10.2147/NDT.S451930. eCollection 2024. Neuropsychiatr Dis Treat. 2024. PMID: 38770534 Free PMC article. Review.
-
Efficacy and safety of esketamine for pediatric gastrointestinal endoscopy: a meta-analysis and trial sequential analysis.Front Pharmacol. 2024 Apr 25;15:1379101. doi: 10.3389/fphar.2024.1379101. eCollection 2024. Front Pharmacol. 2024. PMID: 38725661 Free PMC article.
-
Perioperative Adjunctive Esketamine for Postpartum Depression Among Women Undergoing Elective Cesarean Delivery: A Randomized Clinical Trial.JAMA Netw Open. 2024 Mar 4;7(3):e240953. doi: 10.1001/jamanetworkopen.2024.0953. JAMA Netw Open. 2024. PMID: 38446480 Free PMC article. Clinical Trial.
-
Efficacy of Intravenous Administration of Esketamine in Preventing and Treating Rebound Pain After Thoracic Paravertebral Nerve Block: A Prospective Randomized, Double-Blind, Placebo-Controlled Trial.Drug Des Devel Ther. 2024 Feb 17;18:463-473. doi: 10.2147/DDDT.S448336. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38384750 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical